OcuTerra Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

Read More

Pharma Industry News

OcuTerra Therapeutics moves forward with OTT166 eye drops in Phase 2 trial

OcuTerra Therapeutics, a clinical-stage ophthalmology company, announced the successful full enrollment in its Phase 2 DR:EAM (Diabetic Retinopathy:…

byPallavi Madhiraju

July 19, 2023

web analytics